{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:03Z","timestamp":1786118883239,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,20]]},"abstract":"<jats:sec>\n                    <jats:title>\u00a0<\/jats:title>\n                    <jats:p>Parkinson disease (PD) is a rapidly growing neurodegenerative disorder that presents a significant public health challenge in aging societies, particularly in China. Although genetic, clinical, and environmental risk factors have been well-established, the predictive value of multidimensional factors (encompassing socioeconomic determinants, prodromal functional impairments, and lifestyle) remains underexplored in Chinese populations. We used data from the China Health and Retirement Longitudinal Study (n\u2005=\u200513,649; PD cases\u2005=\u2005269) to develop and validate a machine learning prediction model for PD. Candidate predictors covered cognition, socioeconomic status, comorbidities, and lifestyle. Feature selection was performed using an ensemble approach (boruta, least absolute shrinkage and selection operator, and minimum redundancy maximum relevance), followed by extreme gradient boosting (XGBoost) model development with Bayesian hyperparameter optimization. Data were randomly split into a training set (70%) and a validation set (30%) for internal validation. Model performance was evaluated using area under the receiver operating characteristic curve, decision curve analysis, sensitivity, specificity, positive predictive value, negative predictive value, and F1-score. Model interpretability was evaluated using SHapley Additive exPlanations. Key predictors included cognitive impairment (memory and executive deficits), physical inactivity (low metabolic-equivalent scores), socioeconomic indicators (retirement status and financial support), educational attainment, and comorbidities (e.g., liver disease and wrist pain). In the validation set, the optimized XGBoost model achieved an area under the curve of 0.967 (95% confidence interval 0.962\u20130.972), sensitivity 82.0%, specificity 94.7%, positive predictive value 81.5%, negative predictive value 94.9%, and F1-score 81.7. SHapley Additive exPlanations analyses supported the consistency and relative importance of these predictors. An explainable XGBoost model integrating multidimensional national data showed excellent internal validation performance for identifying individuals with PD in China Health and Retirement Longitudinal Study. This tool may help support PD risk stratification in Chinese populations; external validation and prospective evaluation are warranted before clinical implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000047983","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:00:51Z","timestamp":1774036851000},"page":"e47983","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Developing and validating a clinically actionable prediction tool for Parkinson disease using explainable machine learning with multidimensional national data: A cross-sectional study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9004-3085","authenticated-orcid":false,"given":"Li","family":"Ke","sequence":"first","affiliation":[{"name":"Department of Cerebrovascular Diseases, Suining Central Hospital, Suining, Sichuan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Diseases, Suining Central Hospital, Suining, Sichuan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sili","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Diseases, Suining Central Hospital, Suining, Sichuan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3016-3408","authenticated-orcid":false,"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Diseases, Suining Central Hospital, Suining, Sichuan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"101834","DOI":"10.1016\/j.arr.2022.101834","article-title":"Premotor, nonmotor and motor symptoms of Parkinson\u2019s disease: a new clinical state of the art.","volume":"84","author":"Leite Silva","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease.","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson\u2019s disease and Parkinsonism.","volume":"132","author":"Hayes","year":"2019","journal-title":"Am J Med"},{"key":"R5-20260422","first-page":"101078","article-title":"Disease burden of Parkinson\u2019s disease in China and its provinces from 1990 to 2021: findings from the Global Burden of Disease Study 2021.","volume":"46","author":"Xu","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1002\/mds.28762","article-title":"Prevalence of Parkinson\u2019s disease: a community-based study in China.","volume":"36","author":"Qi","year":"2021","journal-title":"Mov Disord"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mds.25292","article-title":"The current and projected economic burden of Parkinson\u2019s disease in the United States.","volume":"28","author":"Kowal","year":"2013","journal-title":"Mov Disord"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.21037\/apm.2019.10.01","article-title":"Patient and caregiver characteristics associated with caregiver burden in Parkinson\u2019s disease: a palliative care approach.","volume":"9","author":"Macchi","year":"2020","journal-title":"Ann Palliat Med"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease.","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies.","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1007\/s12035-016-0253-0","article-title":"MicroRNAs in cerebrospinal fluid as potential biomarkers for Parkinson\u2019s disease and multiple system atrophy.","volume":"54","author":"Marques","year":"2016","journal-title":"Mol Neurobiol"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3233\/JPD-213135","article-title":"Blood lipid biomarkers in early Parkinson\u2019s disease and Parkinson\u2019s disease with mild cognitive impairment.","volume":"12","author":"Deng","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00702-021-02456-3","article-title":"Parkinson and depression: review and outlook.","volume":"129","author":"Laux","year":"2022","journal-title":"J Neural Transm (Vienna)"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mds.29298","article-title":"Type 2 diabetes and Parkinson\u2019s disease: a focused review of current concepts.","volume":"38","author":"Cullinane","year":"2022","journal-title":"Mov Disord"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.119.044948","article-title":"Association of Parkinson disease with risk of cardiovascular disease and all-cause mortality.","volume":"141","author":"Park","year":"2020","journal-title":"Circulation"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/S0140-6736(22)02040-2","article-title":"Racialising genetic risk: assumptions, realities, and recommendations.","volume":"400","author":"Cerde\u00f1a","year":"2022","journal-title":"Lancet"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease.","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"e59649","DOI":"10.2196\/59649","article-title":"The role of machine learning in cognitive impairment in Parkinson disease: systematic review and meta-analysis.","volume":"27","author":"Wu","year":"2025","journal-title":"J Med Internet Res"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1212\/WNL.0000000000004536","article-title":"A predictive model to identify Parkinson disease from administrative claims data.","volume":"89","author":"Searles Nielsen","year":"2017","journal-title":"Neurology"},{"key":"R20-20260422","doi-asserted-by":"crossref","first-page":"19499","DOI":"10.1038\/s41598-022-24105-9","article-title":"Machine learning based risk prediction for Parkinson\u2019s disease with nationwide health screening data.","volume":"12","author":"Park","year":"2022","journal-title":"Sci Rep"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"e182421","DOI":"10.1001\/jamanetworkopen.2018.2421","article-title":"Association of levels of physical activity with risk of Parkinson disease.","volume":"1","author":"Fang","year":"2018","journal-title":"JAMA Netw Open"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"111860","DOI":"10.1016\/j.diabres.2024.111860","article-title":"Physical activity and sedentary behaviour in relation to body composition, estimated insulin sensitivity and arterial stiffness in adults with type 1 diabetes.","volume":"217","author":"Helleputte","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"R23-20260422","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jamaneurol.2017.2248","article-title":"Association between poor cognitive functioning and risk of incident Parkinsonism: the Rotterdam study.","volume":"74","author":"Darweesh","year":"2017","journal-title":"JAMA Neurol"},{"key":"R24-20260422","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/mds.26373","article-title":"Cognition in individuals at risk for Parkinson\u2019s: Parkinson associated risk syndrome (PARS) study findings.","volume":"31","author":"Chahine","year":"2015","journal-title":"Mov Disord"},{"key":"R25-20260422","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/brain\/aww291","article-title":"Trajectories of prediagnostic functioning in Parkinson\u2019s disease.","volume":"140","author":"Darweesh","year":"2017","journal-title":"Brain"},{"key":"R26-20260422","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.parkreldis.2021.05.027","article-title":"In vivo cholinergic basal forebrain degeneration and cognition in Parkinson\u2019s disease: imaging results from the COPPADIS study.","volume":"88","author":"Grothe","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"R27-20260422","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/jnnp-2019-320450","article-title":"Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease.","volume":"90","author":"Barrett","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R28-20260422","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/brain\/awu323","article-title":"Physical activity and risk of Parkinson\u2019s disease in the Swedish National March Cohort.","volume":"138","author":"Yang","year":"2014","journal-title":"Brain"},{"key":"R29-20260422","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","article-title":"Ascending monoaminergic systems alterations in Alzheimer\u2019s disease. translating basic science into clinical care.","volume":"37","author":"Trillo","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"R30-20260422","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","article-title":"Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways.","volume":"65","author":"Hilker","year":"2005","journal-title":"Neurology"},{"key":"R31-20260422","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1212\/WNL.0b013e3181b0bd3d","article-title":"Cholinergic denervation occurs early in Parkinson disease.","volume":"73","author":"Bohnen","year":"2009","journal-title":"Neurology"},{"key":"R32-20260422","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/mds.25157","article-title":"Dopamine transporter imaging is associated with long-term outcomes in Parkinson\u2019s disease.","volume":"27","author":"Ravina","year":"2012","journal-title":"Mov Disord"},{"key":"R33-20260422","doi-asserted-by":"crossref","first-page":"e71341","DOI":"10.1371\/journal.pone.0071341","article-title":"Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson\u2019s disease.","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"R34-20260422","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.2003.01657.x","article-title":"Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF.","volume":"85","author":"Cohen","year":"2003","journal-title":"J Neurochem"},{"key":"R35-20260422","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0306-4522(03)00096-4","article-title":"Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson\u2019s disease.","volume":"119","author":"Tillerson","year":"2003","journal-title":"Neuroscience"},{"key":"R36-20260422","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3390\/cells12232726","article-title":"The role of cortisol in chronic stress, neurodegenerative diseases, and psychological disorders.","volume":"12","author":"Knezevic","year":"2023","journal-title":"Cells"},{"key":"R37-20260422","doi-asserted-by":"crossref","first-page":"e70016","DOI":"10.1002\/jnr.70016","article-title":"The intricate interplay: microbial metabolites and the gut\u2013liver\u2013brain axis in Parkinson\u2019s disease.","volume":"103","author":"Kishanchand","year":"2025","journal-title":"J Neurosci Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:56:54Z","timestamp":1786035414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047983","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"2025-09-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}